Medicxi Launches Alys Pharmaceuticals in $100m Seed Funding
Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...
- Latest
- Trending
Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...
Toyota's advancements in hydrogen fuel cell technology have revolutionized the automotive industry. With zero emissions and diverse applications, Toyota is ...
Scientists at Delft University of Technology have developed a revolutionary protein analysis technique with high sensitivity, enabling earlier disease detection ...
Insilico Medicine and University of Toronto collaborate to target "undruggable" cancer genes using AI-designed molecules. AI is revolutionizing drug discovery ...
Discover how nanoporous membranes are revolutionizing water filtration. A recent study reveals the importance of nanopore placement for optimal performance. ...
ProAmpac introduces the revolutionary Moisture Protect MP-1000 platforms, eliminating the need for traditional desiccant packets. Ideal for various applications, this ...
Cleveland Clinic and IBM join forces to advance immunotherapy research through AI, unlocking new targets for cancer therapy. #Immunotherapy #AI ...
Pharmaceutical giants Bristol Myers Squibb and Johnson & Johnson invest in Accent Therapeutics, a leading RNA drug developer, contributing to ...
Mirae Asset Capital Life Science, a venture capital firm with $50M funding, aims to support U.S. biotech companies in oncology, ...
A breakthrough in understanding proton-coupled electron transfers could lead to more efficient energy technologies and catalytic reactions. #chemistry #energyconversion
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.